2026 Updates in Cancer Therapies | State-of-the-Art Treating De Novo Multiple Myeloma in 2026

2026 Updates in Cancer Therapies | State-of-the-Art Treating De Novo Multiple Myeloma in 2026

Overview

NA

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Sergio Giralt, MD

Date of Release

January 16th, 2026